Koçárová et al. (2021) proposed psychedelic-induced plasticity (pertaining to both the brain and the mind/psychological phenomena) as a primary transdiagnostic mechanism of change, when treatment occurs within the context of a supportive therapeutic environment and can address universally maladaptive behaviours of brain and mind.
As a reminder, neuroplasticity is where your brain becomes more malleable which can help to repair neural pathways and form new ones (de Vos et al., 2021). The figure below depicts acute-state effects of psychedelics on brain, behaviour, and mind in addition to related longer-term changes in transdiagnostically relevant constructs of psychological flexibility, cognitive flexibility, and mindfulness.
For this interactive, drag the vertical line to the left and right to see and compare both images. If you are using a keyboard, you can use the left and arrow keys.
The acute state and longer-term changes of psychedelics can also be mapped onto the RDoC framework.
While supportive of furthering our understanding of transdiagnostic factors amenable to psychedelic-assisted therapy intervention, the RDoC remains focused on individual biological targets and thus may perpetuate a decontextualized view that ignores socioecological factors and their impact on wellbeing, a previously noted criticism of the RDoC approach.
The Numinus Care Model encourages balancing multiple perspectives, maintaining TVIC and JEDI as orienting principles.
De Vos, C. M. H., Mason, N. L., and Kuypers, K. P. C. (2021). Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. Frontiers in Psychiatry, 12(724606).
Kočárová, R., Horáček, J., and Carhart-Harris, R (2021). Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential? Frontiers in Psychiatry, 12(661233).